Andrew Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: cash-pay shoppers who want the whole price ladder before starting intake
Andrew Meds scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Andrew Meds is a Houston telehealth platform selling compounded semaglutide and tirzepatide on a cash-pay subscription, with clinical care delivered by the Dr Tel X provider network. The full price ladder is published before intake: semaglutide is $199/month month-to-month down to $149 on a 12-month prepay, tirzepatide $299 down to $229. Asynchronous questionnaire care is listed for 44 states, with seven jurisdictions requiring a live visit first.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Andrew Meds
Editorial score · methodology
TMates
Best for: nationwide compounded GLP-1 availability including Puerto Rico
Editorial score · methodology
Editorial score · methodology
Andrew Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Tirzepatide
- Starting price
- $149/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Andrew Meds
Each dimension is scored algorithmically from Andrew Meds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $149/mo, Andrew Meds runs about 12% below the $169 median for GLP-1 providers.
Effectiveness25%
8.1/10Andrew Meds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.3/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-08-27).
Accessibility10%
8.2/10Andrew Meds treats patients in all 50 states.
Support10%
5.8/10Andrew Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Andrew Meds review
Last checked August 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with Andrew Meds
We walked Andrew Meds’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a program from the Weight Loss menu — semaglutide or tirzepatide injections, or the newer oral tirzepatide.
- 2The full price ladder (month-to-month through 12-month prepay) is shown on the product page before anything is entered.
- 3"Get Started" hands off to the intake app at my.andrewmeds.com with a program explainer screen.
- 4A "How It Works" screen sets out the three stages: complete profile, provider review, medication ships.
- 5Choose your state from a list of all 50; the walk was stopped at the following date-of-birth screen.
- Pricing is fully public: both drugs show all four plan lengths with the per-month equivalent and the dollar saving, and every figure is arithmetically correct.
- The state picker offers all 50 states, matching the site's stated 50-state-plus-DC coverage.
- The footer, not the FAQ, carries the useful detail: async questionnaire care in 44 named states, and 7 jurisdictions where a live visit is required before treatment.
- Clinical services are disclosed as a separate entity, Dr Tel X, with its own contact details rather than being folded into the brand.
- No price, discount or urgency timer changed at any point during the walk.
Andrew Meds customer support
- Phone
- (866) 888-6633
- support@drtelx.com
GLP-1 medications Andrew Meds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Andrew Meds's current pricing and active discounts before you decide.
What we like
- The whole price ladder is public before intake — $199/mo month-to-month for semaglutide, $299/mo for tirzepatide, no account required.
- Every advertised prepay saving matches the arithmetic; the $1,788 twelve-month semaglutide plan really is $149/month.
- State coverage is enumerated rather than blanket-claimed: 44 asynchronous states listed by code, plus 7 that require a live visit.
- The prescribing group is named — Dr Tel X — with its own phone, email and mailing address published.
- Medication, supplies and shipping are all stated as included in the subscription price.
- Toll-free phone support is published at (866) 888-6633.
Watch-outs
- The compounding pharmacy is never named; the terms refer only to contracted pharmacies.
- No refunds for partially used subscription periods — refunds are case-by-case at the company's discretion.
- Cancellation needs at least two days' notice before the renewal date, and the first renewal may be charged early.
- Multi-month plans are a single upfront charge, not a reduced monthly bill.
- No LegitScript certification or third-party accreditation is claimed anywhere on the site.
- Seven jurisdictions (DC, KS, LA, MS, NM, RI, WV) cannot use the async path and need a synchronous visit first.
Is Andrew Meds worth it? Our verdict
Andrew Meds positions itself around one thing: cash-pay shoppers who want the whole price ladder before starting intake. It runs $149/month — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
Beyond the core GLP-1 program, Andrew Meds leans on Oral Tirzepatide, All 50 States + DC, and Cash-Pay.
How much Andrew Meds actually costs
- Compounded semaglutide — $199/month
- Compounded semaglutide — $183/month
- Compounded semaglutide — $167/month
- Compounded semaglutide — $149/month
- Compounded tirzepatide — $299/month
- Compounded tirzepatide — $266/month
That puts Andrew Meds below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Gala (about $149/month) is one of the closest alternatives to weigh Andrew Meds against.
Medications: what Andrew Meds prescribes
Andrew Meds prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Andrew Meds's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Andrew Meds is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Andrew Meds treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Andrew Meds earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Andrew Meds scores highest on state availability and ease of access.
Ready to start with Andrew Meds?
Starting at $149/month. See current pricing and start your free consultation.
Andrew Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Andrew Meds review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Andrew Meds's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.